10/26/2026
John J. Giordano's journey from addiction to advocacy
At 80, Giordano champions ibogaine for addiction recovery, leveraging personal history.
Topic archive
5 stories
10/26/2026
At 80, Giordano champions ibogaine for addiction recovery, leveraging personal history.
10/21/2026
Matt Zorn discusses his transition from legal adversary to HHS official.
10/9/2026
Film offers rare insight into psychedelic therapy for trauma and addiction.
9/23/2026
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
8/19/2026
Company aligns with U.S. efforts to advance ibogaine research.